Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rAd-p53 vs Cisplatin for Malignant Pleural Effusion
NCT02429726Phase 2Unknown
- Sponsor
- Shenzhen SiBiono GeneTech
- Start
- Jun 2015
- Primary completion
- Jun 2017
- Modality
- Gene Editing, Gene Silencing, Viral Vectors
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human p53 adenovirus injection in malignant pleural effusion (MPE), sponsored by Shenzhen SiBiono GeneTech. Status: unknown.
02
Drugs
recombinant human p53 adenovirus injection
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT02429726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429726.